FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066109328> ?p ?o ?g. }

• W2066109328 endingPage "1220" @default.
• W2066109328 startingPage "1214" @default.
• W2066109328 abstract "BACKGROUND: Imatinib mesylate (IM) was introduced in chronic myeloid leukemia (CML) treatment in the late 1990s and substantially changed the therapeutic approach to the disease, by inducing complete cytogenetic response (CCR) in approximately 60 percent of cases. Nevertheless, some concerns exist about the duration of response to treatment and the onset of resistance to IM. STUDY DESIGN AND METHODS: Twenty‐five chronic‐phase CML patients in stable CCR (>6 months) treated for at least 1 year with IM at the standard dose (400 mg/day) were mobilized with recombinant human granulocyte–colony‐stimulating factor (Filgrastim) at 10 µg per kg for 4 to 6 days, with the aim of collecting at least 2 × 10 6 CD34+ cells per kg. Standard cytogenetic analysis and first‐round and/or nested polymerase chain reaction were performed in basal and postmobilization samples to examine the presence of bcr‐abl transcripts. RESULTS: CD34+ cells collection was successful in 16 patients, yielding a median of 3.01 × 10 6 ± 1.09 × 10 6 CD34+ cells per kg at the first attempt, and in 4 of the 9 remaining patients who were remobilized after a temporary withdrawal of IM, yielding a median of 2.65 × 10 6 ± 0.7 × 10 6 CD34+ cells per kg, with an overall 80 percent success rate. No correlation between mobilization and duration of the disease, length of IM treatment, or previous interferon‐α and/or hydroxyurea treatment was found. CONCLUSIONS: Autologous CD34+ cells may be mobilized and collected in most CML patients who achieve CCR after IM treatment, with a view to possible use in the event that resistance to IM occurs in patients not eligible for allogeneic peripheral blood progenitor cell transplantation or those lacking an HLA‐matched donor." @default.
• W2066109328 created "2016-06-24" @default.
• W2066109328 creator A5005558035 @default.
• W2066109328 creator A5019747776 @default.
• W2066109328 creator A5024870546 @default.
• W2066109328 creator A5029805362 @default.
• W2066109328 creator A5033633636 @default.
• W2066109328 creator A5050251199 @default.
• W2066109328 creator A5051520180 @default.
• W2066109328 creator A5056136982 @default.
• W2066109328 creator A5066180999 @default.
• W2066109328 creator A5074906580 @default.
• W2066109328 creator A5077252889 @default.
• W2066109328 creator A5083194684 @default.
• W2066109328 creator A5090179703 @default.
• W2066109328 date "2005-06-29" @default.
• W2066109328 modified "2023-10-15" @default.
• W2066109328 title "Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate" @default.
• W2066109328 cites W120419820 @default.
• W2066109328 cites W1894088929 @default.
• W2066109328 cites W1981740211 @default.
• W2066109328 cites W1995874739 @default.
• W2066109328 cites W1997180953 @default.
• W2066109328 cites W1999614615 @default.
• W2066109328 cites W2001575218 @default.
• W2066109328 cites W2011474502 @default.
• W2066109328 cites W2012081403 @default.
• W2066109328 cites W2013850642 @default.
• W2066109328 cites W2016241217 @default.
• W2066109328 cites W2079038989 @default.
• W2066109328 cites W2082580993 @default.
• W2066109328 cites W2100418051 @default.
• W2066109328 cites W2105214030 @default.
• W2066109328 cites W2107582371 @default.
• W2066109328 cites W2139553721 @default.
• W2066109328 cites W2146434689 @default.
• W2066109328 cites W2167552642 @default.
• W2066109328 cites W2171722798 @default.
• W2066109328 doi "https://doi.org/10.1111/j.1537-2995.2005.00175.x" @default.
• W2066109328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15987369" @default.
• W2066109328 hasPublicationYear "2005" @default.
• W2066109328 type Work @default.
• W2066109328 sameAs 2066109328 @default.
• W2066109328 citedByCount "14" @default.
• W2066109328 countsByYear W20661093282023 @default.
• W2066109328 crossrefType "journal-article" @default.
• W2066109328 hasAuthorship W2066109328A5005558035 @default.
• W2066109328 hasAuthorship W2066109328A5019747776 @default.
• W2066109328 hasAuthorship W2066109328A5024870546 @default.
• W2066109328 hasAuthorship W2066109328A5029805362 @default.
• W2066109328 hasAuthorship W2066109328A5033633636 @default.
• W2066109328 hasAuthorship W2066109328A5050251199 @default.
• W2066109328 hasAuthorship W2066109328A5051520180 @default.
• W2066109328 hasAuthorship W2066109328A5056136982 @default.
• W2066109328 hasAuthorship W2066109328A5066180999 @default.
• W2066109328 hasAuthorship W2066109328A5074906580 @default.
• W2066109328 hasAuthorship W2066109328A5077252889 @default.
• W2066109328 hasAuthorship W2066109328A5083194684 @default.
• W2066109328 hasAuthorship W2066109328A5090179703 @default.
• W2066109328 hasConcept C10205521 @default.
• W2066109328 hasConcept C126322002 @default.
• W2066109328 hasConcept C203014093 @default.
• W2066109328 hasConcept C2776694085 @default.
• W2066109328 hasConcept C2777583451 @default.
• W2066109328 hasConcept C2777767877 @default.
• W2066109328 hasConcept C2778729363 @default.
• W2066109328 hasConcept C2779171977 @default.
• W2066109328 hasConcept C2779282312 @default.
• W2066109328 hasConcept C2780007613 @default.
• W2066109328 hasConcept C28328180 @default.
• W2066109328 hasConcept C3019892230 @default.
• W2066109328 hasConcept C54355233 @default.
• W2066109328 hasConcept C71924100 @default.
• W2066109328 hasConcept C86803240 @default.
• W2066109328 hasConcept C90924648 @default.
• W2066109328 hasConceptScore W2066109328C10205521 @default.
• W2066109328 hasConceptScore W2066109328C126322002 @default.
• W2066109328 hasConceptScore W2066109328C203014093 @default.
• W2066109328 hasConceptScore W2066109328C2776694085 @default.
• W2066109328 hasConceptScore W2066109328C2777583451 @default.
• W2066109328 hasConceptScore W2066109328C2777767877 @default.
• W2066109328 hasConceptScore W2066109328C2778729363 @default.
• W2066109328 hasConceptScore W2066109328C2779171977 @default.
• W2066109328 hasConceptScore W2066109328C2779282312 @default.
• W2066109328 hasConceptScore W2066109328C2780007613 @default.
• W2066109328 hasConceptScore W2066109328C28328180 @default.
• W2066109328 hasConceptScore W2066109328C3019892230 @default.
• W2066109328 hasConceptScore W2066109328C54355233 @default.
• W2066109328 hasConceptScore W2066109328C71924100 @default.
• W2066109328 hasConceptScore W2066109328C86803240 @default.
• W2066109328 hasConceptScore W2066109328C90924648 @default.
• W2066109328 hasIssue "7" @default.
• W2066109328 hasLocation W20661093281 @default.
• W2066109328 hasLocation W20661093282 @default.
• W2066109328 hasOpenAccess W2066109328 @default.
• W2066109328 hasPrimaryLocation W20661093281 @default.
• W2066109328 hasRelatedWork W130519244 @default.
• W2066109328 hasRelatedWork W1861808521 @default.

• next